Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients

Diabetes Research and Clinical Practice

Volumn 84, Issue 2, 2009, Pages 174-178

  de Luis, D A ^a   Sagrado, M Gonzalez ^a   Conde, R ^a   Aller, R ^a   Izaola, O ^a   Perez Castrillon, J L ^a   Duenas A ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Adipocytokines; Anthropometry; Cardiovascular risk factors; Obesity; Resistin

Indexed keywords

RESISTIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIASTOLE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RESISTIN; TRIGLYCERIDES;

EID: 63949085786     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.01.017     Document Type: Article

References (27)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115 (2005) 911-919
2. Meier U., and Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin. Chem. 50 (2004) 1511-1525
3. Matsuda M., Shimomura I., and Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 277 (2002) 37487-37491
4. Steppan C.M., Bailey S.T., and Bhat S. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
5. Satoh H., Nguyen M.T., Miles P.D., Immamura T., Usui I., and Olefsky J.M. Adenovirus-mediated chronic hyper resistinemia leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114 (2004) 224-231
6. Steppan C.M., and Lazar M.A. The current biology of resistin. J. Intern. Med. 255 (2004) 439-447
7. Sato N., Kobayashi K., Inoguchi T., Sonoda N., Immamura M., Sekiguchi N., et al. Adenovirus-mediated high expression of resistin causes dyslipemia in mice. Endocrinology 146 (2005) 273-279
8. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., et al. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114 (2004) 232-239
9. Pagano C., Marin O., Calcagno A., Schiappelli P., Pilon C., Milan G., et al. Increased serum resistin in adults with Prader Willi syndrome is related to obesity and not to insulin resistance. J. Clin. Endocrinol. Metab. 90 (2005) 4335-4340
10. Burnett M.S., Devaney J.M., Adenika R.J., Lindsay R., and Howard B.V. Cross-sectional associations of resistin, coronary heart disease and insulin resistance. J. Clin. Endocrinol. Metab. 91 (2006) 64-68
11. Zou C.C., Liang L., Hong F., Fu J.F., and Zhao Z.Y. Serum adiponectin, resistin levels and non alcoholic fatty liver disease in obese children. Endocrine J. 52 (2005) 519-524
12. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., and Treacher D. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-414
13. Feurer I.D., and Mullen J.L. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry. Nutr. Clin. Pract. 1 (1986) 43-49
14. Lukaski H., and Johson P.E. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 41 4 (1985) 810-817
15. Shetty G., Economides P., Horton E., Mantzmoros C., and Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2454
16. Azuma K., Katsukawa E., Oguchi S., Murata M., Yamazaki H., Shimada A., et al. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 11 (2003) 997-1001
17. Pfutzner A., Langenfeld M., Kunt T., Lobig M., and Forst T. Evaluation of human resitin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin. Lab. 49 (2003) 571-576
18. Iqbal N., Seshadri P., Stern L., Loh J., Kundu S., Jafar T., et al. Serum resitin is not associated with obesity or insulin resistance in humans. Eur. Rev. Med. Pharmacol. Sci. 9 (2005) 161-165
19. Utzschneider K.M., Carr D.B., Tong J., Wallace T.M., Hull R.L., Zraika S., et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48 (2005) 2330-2333
20. Norata G.D., Ongari M., Garlaschelli K., Raselli S., Grigore L., and Catapano L. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur. J. Endocrinol. 156 (2007) 279-284
21. Verma S., Li S.H., Wang C.H., Fedak P.W., Li R.K., and Weisel R.D. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 6 (2003) 736-740
22. Chen C.C., Li T.C., Li C.I., Liu C.S., Wang H.J., and Lin C.C. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 54 (2005) 471-475
23. Pischon T., Bamberger C.M., Kratzsch J., Zyriax B.C., Algenstaedt P., Boeing H., et al. Association of plasma resistin levels with coronary heart disease in women. Obes. Res. 13 (2005) 1764-1771
24. Kunnari A., Ukkola O., Paivansali M., and Kesaniemi Y.A. High plasma resistin level is associated with enhanced hsCRP and leucocytes. J. Clin. Endocrine Metab. 91 (2006) 2755-2760
25. Bo S., Gambino R., Pagani A., Guidi S., Gentile L., Cassader M., et al. Relationships between human serum resitin inflammatory markers and insulin resistance. Int. J. Obes. 29 (2005) 1315-1320
26. Lehrke M., Reilly M.P., Millingyon S.C., Iqbal N., Rader D.J., and Lazar M.A. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med. 1 (2004) e45
27. Chu N., Kong A.P.S., Kim D.D., Amstrond D., Baxi S., Deustch R., et al. Differential effects of metformin and troglitaznoe on cardiovascular risk factors in patients with DM2. Diabetes Care 25 (2002) 542-548